Telix Pharmaceuticals | TLX - Capitale Ordinario

Prezzo Delle Azioni
14.64
Cambio Giornaliero
1.00 7.33%
Mensile
36.06%
Annuale
-44.10%
Q2 Previsione
12.67




Capitale Ordinario Cambiamento Data
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Medical Developments International AUD 112.66M 2.35M 2025-12
Mesoblast USD 1.29B 8.58M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Pacific Edge NZD 1.02B 210.22M 2025-12
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
Polynovo AUD 690.84M 991 2025-12
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 145.66M 279.42K 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12